Cara Therapeutics (CARA) PT Lowered to $25 at Piper Sandler
Tweet
Share
E-mailGet Alerts CARA Hot Sheet
Price: $5.32 --0%
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Rating Summary:
6 Buy, 5 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 11
Join SI Premium – FREE
Piper Sandler analyst David Amsellem lowered the price target on Cara Therapeutics (NASDAQ: CARA) to $25.00 (from $30.00) while maintaining a rating.
You May Also Be Interested In
- CIBC Upgrades PRO REIT (PRV-U:CN) to Outperformer
- Cascades Inc. (CAS:CN) (CADNF) PT Raised to Cdn$20.50 at Scotiabank
- Canadian Tire Corp Ltd. (CTC/A:CN) (CDNAF) PT Raised to Cdn$200 at Scotiabank
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
